<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:dn="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85160029885</prism:url><dc:identifier>SCOPUS_ID:85160029885</dc:identifier><eid>2-s2.0-85160029885</eid><prism:doi>10.1002/btpr.3365</prism:doi><article-number>e3365</article-number><dc:title>Use of single analytic tool to quantify both absolute N-glycosylation and glycan distribution in monoclonal antibodies</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><citedby-count>1</citedby-count><prism:publicationName>Biotechnology Progress</prism:publicationName><dc:publisher>John Wiley and Sons Inc</dc:publisher><source-id>15541</source-id><prism:issn>15206033 87567938</prism:issn><prism:volume>39</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2023-09-01</prism:coverDate><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag><dc:creator><author seq="1" auid="57222085768"><ce:initials>L.</ce:initials><ce:indexed-name>Mao L.</ce:indexed-name><ce:surname>Mao</ce:surname><ce:given-name>Leran</ce:given-name><preferred-name><ce:initials>L.</ce:initials><ce:indexed-name>Mao L.</ce:indexed-name><ce:surname>Mao</ce:surname><ce:given-name>Leran</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57222085768</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></dc:creator><dc:description><abstract xmlns="" original="y" xml:lang="eng"><publishercopyright>© 2023 The Authors. Biotechnology Progress published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.</publishercopyright><ce:para>Recombinant proteins represent almost half of the top selling therapeutics—with over a hundred billion dollars in global sales—and their efficacy and safety strongly depend on glycosylation. In this study, we showcase a simple method to simultaneously analyze N-glycan micro- and macroheterogeneity of an immunoglobulin G (IgG) by quantifying glycan occupancy and distribution. Our approach is linear over a wide range of glycan and glycoprotein concentrations down to 25 ng/mL. Additionally, we present a case study demonstrating the effect of small molecule metabolic regulators on glycan heterogeneity using this approach. In particular, sodium oxamate (SOD) decreased Chinese hamster ovary (CHO) glucose metabolism and reduced IgG glycosylation by 40% through upregulating reactive oxygen species (ROS) and reducing the UDP-GlcNAc pool, while maintaining a similar glycan profile to control cultures. Here, we suggest glycan macroheterogeneity as an attribute should be included in bioprocess screening to identify process parameters that optimize culture performance without compromising antibody quality.</ce:para></abstract></dc:description><link href="https://api.elsevier.com/content/abstract/scopus_id/85160029885" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85160029885&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85160029885&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"><affilname>Carnegie Mellon University</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><authors><author seq="1" auid="57222085768"><ce:initials>L.</ce:initials><ce:indexed-name>Mao L.</ce:indexed-name><ce:surname>Mao</ce:surname><ce:given-name>Leran</ce:given-name><preferred-name><ce:initials>L.</ce:initials><ce:indexed-name>Mao L.</ce:indexed-name><ce:surname>Mao</ce:surname><ce:given-name>Leran</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57222085768</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author><author seq="2" auid="55465891400"><ce:initials>J.W.</ce:initials><ce:indexed-name>Schneider J.W.</ce:indexed-name><ce:surname>Schneider</ce:surname><ce:given-name>James W.</ce:given-name><preferred-name><ce:initials>J.W.</ce:initials><ce:indexed-name>Schneider J.W.</ce:indexed-name><ce:surname>Schneider</ce:surname><ce:given-name>James W.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/55465891400</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author><author seq="3" auid="7403387058"><ce:initials>A.S.</ce:initials><ce:indexed-name>Robinson A.S.</ce:indexed-name><ce:surname>Robinson</ce:surname><ce:given-name>Anne S.</ce:given-name><preferred-name><ce:initials>A.S.</ce:initials><ce:indexed-name>Robinson A.S.</ce:indexed-name><ce:surname>Robinson</ce:surname><ce:given-name>Anne S.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7403387058</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></authors></abstracts-retrieval-response>